Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the safety and efficacy of Axatilimab in combination with ruxolitinib for newly diagnosed chronic graft-versus-host dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Axatilimab (axatilimab)
• Ruxolitinib (ruxolitinib)

Snippet

Sponsor: Incyte Corporation | Conditions: Chronic Graft-versus-host-disease | Phase 2 | Status: RECRUITING